Dimethyl fumarate alters B‐cell memory and cytokine production in MS patients
Lists
Only you see this
Abstract
We evaluated the effect of dimethyl fumarate (DMF) treatment on B-cell memory and cytokine production in 18 patients with relapsing remitting multiple sclerosis (RRMS) using peripheral blood mononuclear cells obtained prior to and at 6 months post-DMF initiation. We noted a decline in the absolute B-cell number with DMF treatment, with a preferential depletion of memory B cells and a concurrent increase in naïve B cells. We noted significant reductions in GM-CSF, TNF-<i>α</i>, and IL-6 producing B cells with DMF treatment. These effects on the B-cell compartment may underlie the beneficial effects of DMF in RRMS.
BibTeX
@article{smith2017dimethyl,
author = {Matthew D. Smith and Kyle Martin and Peter A. Calabresi and Pavan Bhargava},
title = {{Dimethyl fumarate alters B‐cell memory and cytokine production in MS patients}},
journal = {Annals},
year = {2017},
doi = {10.1002/acn3.411},
}Loading related content...